(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies
NCT05384509
·
clinicaltrials.gov ↗
RECRUITING
Status
320
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DIAGNOSTIC_TEST:
solid organ malignancies treatment
Sponsor
Chang Gung Memorial Hospital